Figure 3From: Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS) Coexistence of predominant gastroesophageal reflux disease (GERD) symptoms, predominant dyspeptic symptoms and predominant other upper gastrointestinal symptoms, according to the symptom with the highest Global Overall Severity score at baseline. A joint highest score for more than one symptom was possible. GERD symptoms included heartburn and regurgitation; dyspeptic symptoms included epigastric pain, postprandial fullness and early satiety; and other symptoms included nausea/vomiting, belching and bloating.Back to article page